283 Genetic Variants in the TGF-β1 Gene and the Risk of Late Toxicity After Radiotherapy in Prostate Cancer Patients

MLA

Thurner, E. M., et al. “283 Genetic Variants in the TGF-Β1 Gene and the Risk of Late Toxicity After Radiotherapy in Prostate Cancer Patients.” European Journal of Cancer, vol. 48, Nov. 2012, p. 87. EBSCOhost, https://doi.org/10.1016/S0959-8049(12)72081-6.

APA

Thurner, E. M., Krenn-Pilko, S., Renner, W., Gerger, A., Kapp, K. S., Langsenlehner, U., & Langsenlehner, T. (2012). 283 Genetic Variants in the TGF-β1 Gene and the Risk of Late Toxicity After Radiotherapy in Prostate Cancer Patients. European Journal of Cancer, 48, 87. https://doi.org/10.1016/S0959-8049(12)72081-6

Chicago

Thurner, E.M., S. Krenn-Pilko, W. Renner, A. Gerger, K.S. Kapp, U. Langsenlehner, and T. Langsenlehner. 2012. “283 Genetic Variants in the TGF-Β1 Gene and the Risk of Late Toxicity After Radiotherapy in Prostate Cancer Patients.” European Journal of Cancer 48 (November): 87. doi:10.1016/S0959-8049(12)72081-6.